drugset / Trial / NCT05551013
Treatment of Recurrent GBM With APG-157 Via Expanded Access
Summary
This expanded access request will evaluate APG-157, a botanical drug under development for other cancers, as potential treatment for recurrent Glioblastoma multiforme (GBM) patients.
Timeline
- Start
- —
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | APG-157 | Unknown | — | Oral |